Back to top
Celvestrant 250 mg PFS
Celvestrant 250 mg PFS

Celvestrant 250 mg PFS

Celvestrant 250 mg PFS Specification

  • Pacakaging (Quantity Per Box)
  • 1 Pre-filled Syringe
  • Salt Composition
  • Fulvestrant
  • Origin of Medicine
  • Synthetic
  • Drug Type
  • Anticancer Drug
  • Ingredients
  • Fulvestrant 250 mg
  • Physical Form
  • Pre-filled Syringe (PFS)
  • Function
  • Hormonal Therapy for Breast Cancer
  • Recommended For
  • Postmenopausal Women with Hormone Receptor-Positive Advanced Breast Cancer
  • Dosage
  • 250 mg administered intramuscularly
  • Dosage Guidelines
  • Administer 250 mg every two weeks for the first three doses followed by 250 mg once monthly thereafter
  • Suitable For
  • Adults specifically postmenopausal women
  • Quantity
  • 1 syringe per box
  • Storage Instructions
  • Store refrigerated at 2C to 8C (36F to 46F) do not freeze and protect from light
 
 

About Celvestrant 250 mg PFS



Celvestrant 250 mg PFS is a potent Anticancer Drug containing 250 mg of Fulvestrant in each Pre-filled Syringe (PFS). It is designed for Hormonal Therapy in postmenopausal women with Hormone Receptor-Positive Advanced Breast Cancer. This synthetic medication is administered intramuscularly with a dosage of 250 mg every two weeks for the first three doses followed by 250 mg monthly. Each box contains 1 syringe and should be stored refrigerated at 2C to 8C, protected from light.

FAQs of Celvestrant 250 mg PFS:


Q: What is Celvestrant 250 mg PFS used for?

A: Celvestrant 250 mg PFS is used for Hormonal Therapy in postmenopausal women with Hormone Receptor-Positive Advanced Breast Cancer.

Q: How should Celvestrant 250 mg PFS be stored?

A: Celvestrant 250 mg PFS should be stored refrigerated at 2C to 8C, and protected from light.

Q: What is the dosage recommendation for Celvestrant 250 mg PFS?

A: The recommended dosage is 250 mg administered intramuscularly every two weeks for the first three doses, followed by 250 mg monthly thereafter.

Q: Is Celvestrant 250 mg PFS suitable for all adults?

A: Celvestrant 250 mg PFS is specifically suitable for postmenopausal women.

Q: What is the salt composition of Celvestrant 250 mg PFS?

A: The salt composition of Celvestrant 250 mg PFS is Fulvestrant.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Anti-Cancer Category

Toposide 100 mg Injection

Toposide 100 mg Injection

Storage Instructions : Store below 25C protect from light and retain in original pack until use.

Ingredients : Etoposide

Pacakaging (Quantity Per Box) : 1 vial per box

Physical Form : Other, Injection

Suitable For : Adults

Quantity : 1 vial

Paclitero 260 mg Injection

Paclitero 260 mg Injection

Storage Instructions : Store below 25C protect from light and do not freeze

Ingredients : Paclitaxel

Pacakaging (Quantity Per Box) : 1 vial per box

Physical Form : Liquid Injection, Other

Suitable For : Adults

Quantity : 1 vial (260 mg per vial)

Bdparib 200 mg Tablet

Bdparib 200 mg Tablet

Storage Instructions : Store in a cool dry place away from direct sunlight

Ingredients : Niraparib

Pacakaging (Quantity Per Box) : 10 strips of 10 tablets each

Physical Form : Tablet, Other

Suitable For : Other, Adult patients

Quantity : Available in strips of 10 tablets

Docax 20 mg Injection

Docax 20 mg Injection

Storage Instructions : Store at a temperature of 2C to 8C in a refrigerator and protect from light.

Ingredients : Docetaxel

Pacakaging (Quantity Per Box) : 1 vial per box

Physical Form : Liquid

Suitable For : Adults undergoing cancer treatment, Other

Quantity : 1 vial